| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
TXT
|
Shawn Anderson
|
||||||
| GSE61134 |
Androgen receptor gene aberrations in circulating cell-free DNA: biomarkers of therapeutic resistance and response in castration-resistant prostate cancer
|
62 |
|
Shawn Anderson | Mar 09, 2015 | |||
| GSE80356 |
Angiopoietin-like 4 enhances the ability of tendon fibroblasts to undergo proliferation and migration
|
9 |
|
Shawn Anderson | Apr 17, 2016 | |||
| GSE77516 |
BIRC6-targeting as potential therapy for advanced, enzalutamide-resistant prostate cancer
|
8 |
|
Shawn Anderson | Feb 04, 2016 | |||
| GSE67256 |
Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis
|
6 |
|
Shawn Anderson | Mar 01, 2016 | |||
| GSE48667 |
Enhancement by Aneustat (OMN54) of docetaxel anticancer activity in a patient-derived prostate cancer tissue xenograft model
|
8 |
|
Shawn Anderson | Oct 23, 2014 | |||
| GSE49342 |
GATA2 as a potential prostate cancer metastasis-driving gene
|
8 |
|
Shawn Anderson | Jan 20, 2014 | |||
| GSE55345 |
Generation 2.5 Antisense Oligonucleotides Targeting the Androgen Receptor and its Splice Variants Suppress Enzalutamide-Resistant Prostate Cancer Cell Growth
|
6 |
|
Shawn Anderson | Jan 01, 2015 | |||
| GSE55016 |
Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer
|
28 |
|
Shawn Anderson | Jul 21, 2014 | |||
| GSE41193 |
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development
|
56 |
|
Shawn Anderson | Jan 12, 2013 | |||
| GSE41188 |
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development (aCGH)
|
24 |
|
Shawn Anderson | Jan 12, 2013 | |||
| GSE41192 |
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development (expression)
|
32 |
|
Shawn Anderson | Jan 12, 2013 | |||
| GSE61214 |
Identification of DEK as a potential therapeutic target for Neuroendocrine prostate cancer
|
4 |
|
Shawn Anderson | Jan 15, 2015 | |||
| GSE34649 |
Integrated genome and transcriptome sequencing identifies a novel case of hybrid and aggressive prostate cancer
|
5 |
|
Shawn Anderson | Dec 22, 2011 | |||
| GSE86942 |
RNA Splicing of the BHC80 gene Facilitates Neuroendocrine Prostate Cancer Progression
|
9 |
|
Shawn Anderson | Sep 15, 2016 | |||
| GSE44319 |
The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity cancer.
|
52 |
|
Shawn Anderson | Feb 15, 2013 | |||
| GSE59986 |
The placental gene PEG10 promotes progression of neuroendocrine prostate cancer
|
20 |
|
Shawn Anderson | Jan 05, 2015 | |||
| GSE59984 |
The placental gene PEG10 promotes progression of neuroendocrine prostate cancer [Expression]
|
14 |
|
Shawn Anderson | Jan 05, 2015 | |||
| GSE59985 |
The placental gene PEG10 promotes progression of neuroendocrine prostate cancer [aCGH]
|
6 |
|
Shawn Anderson | Jan 05, 2015 | |||
| GSE78245 |
The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells
|
12 |
|
Shawn Anderson | Feb 24, 2016 | |||
| GSE66852 |
Therapy-Induced Developmental Reprogramming of Prostate Cancer Cells and Acquired Resistance
|
30 |
|
Shawn Anderson | Mar 11, 2016 |
